are prominently advertised.

+Hospitals.+--In the second place there must be hospital facilities.
They must not be venereal hospitals, but services or parts of general
hospitals, so that patients who are received into them will be protected
from stigma and comment. Pontopidan, a Danish expert, estimated that for
the care of venereal disease one hospital bed to every 2000 of
population was insufficient, and yet there are cities in this country
which do not have one bed available for the purpose to 100,000 people.
The hospital performs a peculiarly valuable function in the care of
syphilis in particular. It provides for temporary quarantine, and for
the education of the patient in his responsibility to the community when
he is discharged. Three weeks or more under hospital direction is the
best possible start for an active syphilis that is to be cured. The
privacy of a syphilitic can be protected in a hospital as successfully
as in a specialist's office, and the quality of treatment which can be
given him is distinctly better than he can obtain while out and around.
Hospitals in general have kept their doors closed to syphilis until
recently, and it is only under the pressure of a growing understanding
of what this means to the public health that they are awakening to their
duty.

+Cheap Salvarsan.+--Before a general campaign for the successful
treatment of syphilis can be made a fact, salvarsan must become, as has
already been pointed out, a public and not a private asset. It must be
available to all who need it at the lowest possible cost[17]--practically
that of manufacture--and must be supplied by the state when necessary.
The granting of patent rights which make possible the present
exploitation for gain of such vital agents in the protection of the
public health is a mistake which we should lose no time in remedying.
While salvarsan does not mean the cure of syphilis, it does mean a
large part of its control as an infectious disease. When it can be given
only to the person who can muster from five to twenty-five dollars for
each dose which he receives, it is evident that its usefulness is likely
to be seriously restricted.

[17] The price of salvarsan before the war was $3.50 per full dose
for the drug alone. It can be profitably marketed at less than $1.00
per dose. The patent rights have been temporarily suspended during
the war, and their renewal by Congress should not be permitted.

+Reducti